Treatment begins low and is stepped up over weeks or months a process called titration
Semaglutide is not recommended in patients with heart failure New York Heart Association class IV
In conclusion, our real-world study demonstrates that the use of GLP-1 RAs may not be associated with an increased risk of mood/behavior disorders, including depression, anxiety, and suicidal behavior
Thyroid function, cortisol levels, and nutrient status (particularly B12 and caloric intake adequacy) can indicate whether weight plateau or gain stems from medical rather than behavioral factors
Genetic factors affecting gene transcription and catalytic activity of UDPglucuronosyltransferases in human liver
Outside of telehealth, a range of existing solutions have pivoted and seen success in the rise of GLP-1 use